Moderna Shares Rise Over 12% to Reach New 52-Week High
Moderna (MRNA) shares surged over 12%, closing at $172.94 on Monday and setting a new 52-week high. The stock gained $18.90 during the session, continuing its recent pattern of volatile trading. The rally followed an announcement from Moderna regarding late-breaking data related to one of its mRNA-based therapies. While specific details were not provided in the summary text, such updates often influence investor sentiment and market performance for biotech firms like Moderna.
Tickers: $MRNA